Trial
NCT01031953
Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
OHSU Knight Cancer Institute
Collaborators
National Cancer Institute (NCI)
Condition
Breakthrough Nausea and Vomiting
Intervention
fosaprepitant dimeglumine
Why stopped
Drug contract timelines and inadequate enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-05-09